ViroLogik

PharmaceuticalsSeries CJena, Germanyvirologik.com

Latest round

Series C

Last raised

May 2010

Total raised

$24M

Investors

4

About ViroLogik

Established in 2006 and based in Germany, ViroLogik is a biopharmaceutical company which develops drugs for treatment of viral diseases.

Who invested in ViroLogik

4 investors across 4 rounds

See all investors in ViroLogik

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    May 1, 2010

    Amount

    $9.1M

    Investors

    Locked

  2. Series B

    Dec 10, 2008

    Amount

    $9.5M

    Investors

    Locked

  3. Series A

    Feb 15, 2007

    Amount

    $5.2M

    Investors

    Locked

  4. Seed

    Mar 1, 2006

    Amount

    $0.4M

    Investors

    Locked

Questions about ViroLogik

Who invested in ViroLogik?

ViroLogik has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ViroLogik raised?

ViroLogik has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did ViroLogik last raise money?

ViroLogik's most recent round on record is a Series C, in May 2010.

What does ViroLogik do?

Established in 2006 and based in Germany, ViroLogik is a biopharmaceutical company which develops drugs for treatment of viral diseases.

Where is ViroLogik headquartered?

ViroLogik is headquartered in Jena, Germany.

Which VCs invest in companies like ViroLogik?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at ViroLogik's stage. Their profiles are linked below.

Raising like ViroLogik? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.